Literature DB >> 7389720

Radiation absorbed dose estimates to the embryo from some nuclear medicine procedures.

V Husák, M Wiedermann.   

Abstract

Using the specific absorbed fractions reported by Smith and Warner, the radiation doses absorbed by the embryo in early pregnancy were calculated for various radiopharmaceuticals used in the diagnostic procedures of nuclear medicine. Radiopharmaceuticals are considered which are excreted predominantly through urine and cause the doses to the embryo to be 40%--90% higher than gonad doses. Also discussed are large differences of doses reported by various authors to the embryo by 99mTc-pertechnetate.

Mesh:

Substances:

Year:  1980        PMID: 7389720     DOI: 10.1007/bf00271900

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Summary of current radiation dose estimates to humans from 123I, 124I, 125I, 126I, 130I, 131I, and 132I as sodium iodide.

Authors: 
Journal:  J Nucl Med       Date:  1975-09       Impact factor: 10.057

2.  MIRD/Dose Estimate Report No. 8. Summary of current radiation dose estimates to normal humans from 99mTc as sodium pertechnetate.

Authors: 
Journal:  J Nucl Med       Date:  1976-01       Impact factor: 10.057

3.  Estimates of radiation dose to the embryo from nuclear medicine procedures.

Authors:  E M Smith; G G Warner
Journal:  J Nucl Med       Date:  1976-09       Impact factor: 10.057

4.  Letter: Radioisotopes and the "10-day Rule".

Authors:  R Sear
Journal:  Br J Radiol       Date:  1974-11       Impact factor: 3.039

5.  Experimental comparison of radioactive agents for studies of the placenta.

Authors:  D F Mahon; J G McAfee
Journal:  J Nucl Med       Date:  1973-09       Impact factor: 10.057

6.  Mird-dose estimate report no. 2. Summary of current radiation dose estimates to humans from 66Ga-, 68Ga-, and 72Ga-citrate.

Authors: 
Journal:  J Nucl Med       Date:  1973-10       Impact factor: 10.057

7.  The application of the "ten-day rule" in radiopharmaceutical investigations. A report of a working party of the M.R.C. Isotope Advisory Panel.

Authors:  R E Ellis; B E Nordin; P Tothill; N Veall
Journal:  Br J Radiol       Date:  1977-03       Impact factor: 3.039

8.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors:  G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

9.  Radiation damage to mouse testis cells from [99mTc] pertechnetate.

Authors:  T A Mian; N Suzuki; H J Glenn; T P Haynie; M L Meistrich
Journal:  J Nucl Med       Date:  1977-11       Impact factor: 10.057

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.